[退出]
EN
  • 南方网

  • 南方日报

  • 南方都市报

  • 南方杂志

更多新闻
推广

招聘信息     网络举报APP下载     粤运美好出行     白云松涛     广州仲裁委员会网络送达公告     涉未成年人网络有害信息举报专区      健康科普      最闪亮的坐标      我们的新时代

News Guangdong

Guangdong to invest 230 billion RMB in highways and waterways in 2023

Guangdong to invest 230 billion RMB in highways and waterways in 2023

The transportation network of Guangdong province will be further improved in 2023, with an investment of 230 billion RMB in highways and waterways.
Guangzhou's Liwan sets 2023 GDP target of over 6.5%

Guangzhou's Liwan sets 2023 GDP target of over 6.5%

The Liwan District of Guangzhou announced GDP growth of more than 6.5 percent for 2023, with fixed asset investment growth of 20 percent.
Enterprises show confidence in Guangzhou's high-quality business development

Enterprises show confidence in Guangzhou's high-quality business development

Guangzhou held a business meeting for high-quality development on January 30. Participating businesses shared their current development opportunities and challenges, as well as their long-term plans to support the city's high-quality development.
High-profile scholar: Guangdong sends strong signal to attract high-quality resources worldwide

High-profile scholar: Guangdong sends strong signal to attract high-quality resources worldwide

Zheng Yongnian sheds light on the High-quality Development Conference which was held in South China’s Guangdong province, the province with the largest GDP in China for 34 consecutive years, on January 28, the first working day after the Chinese New Year holiday.
1/0
"My Guangdong Story" Video Solicitation 20th CPC National Congress

Guangdong police all out for safe Chinese New Year holiday

Guangdong police all out for safe Chinese New Year holiday

During the 7-day Chinese New Year holiday, traffic accidents in Guangdong decreased by 60.53 percent year-on-year and criminal cases by 1.51 percent year-on-year. No severe traffic congestion occurred on major roads.

​Chinese COVID-19 antiviral drug (VV116) hits the market

​Chinese COVID-19 antiviral drug (VV116) hits the market

According to the National Medical Products Administration, China recently granted provisional approval to Shanghai Wangshi Biomedical Technology Co., Ltd.'s application to administer oral antiviral treatments for COVID-19, also known as VV116.